|
| |
Mimotopes Launches Online Peptide
Superstore
- First eCommerce site dedicated to peptides and
related products:
www.mimotopes.com
- Wide range of new peptide synthesis reagents and
catalogue peptides
- New pricing positions Mimotopes as the supplier of
the world’s most affordable high-quality peptides
Melbourne, Australia – October 21, 2009 – Mimotopes Pty
Ltd, a subsidiary of Commonwealth Biotechnologies Inc. (NASDAQ Capital Market:
CBTE), is pleased to announce the launch of a new multi-currency online peptide
superstore dedicated to the design, quoting, and ordering of peptides and
related products. The launch of the new peptide eCommerce website comes together
with an expanded range of catalogue products, including cosmetic and
pharmaceutical peptides, bulk amino acids and peptide synthesis reagents. This
new channel to market, together with a recent expansion in production capacity,
has allowed Mimotopes to significantly reduce the pricing of its custom peptide
and peptide library offerings, whilst maintaining its strong reputation for
quality and customer service. The new pricing brings Mimotopes into the position
of global price leader for many of its products and services.
Mimotopes is the founder of peptide library technology and has over 20 years
experience in designing and synthesizing custom peptide libraries and individual
custom peptides. This experience has been captured in the new website, which
features online synthesis assessment, quoting, and ordering of individual custom
peptides and a capability to order multiple custom peptides via spreadsheet
upload. Mimotopes has also developed web versions of eight of its most popular
peptide library design tools. These tools guide users through the steps of
isolating minimum length active peptide sequences, identifying critical amino
acid residues in and designing analogues for sequence optimization. Finally, the
online catalogue lists over 5,000 high-quality pre-synthesized peptides, peptide
synthesis reagents and combinatorial chemistry products stocked by Mimotopes.
According to CEO, Dr. Nick Ede, “Mimotopes’ Online Superstore addresses the
needs of researchers involved in all aspects of peptide science, including
peptide production, bioassay development, epitope mapping, proteomics, target
discovery and lead optimization. We have over 20 years of experience in working
with peptides and this has provided us with skills in peptide design, production
and analysis that are second-to-none. The new site reflects much of our
experience and includes intelligent features such as an assessment tool for
identifying potential synthesis or solubility issues based on the amino acid
sequence.”
Peptides represent one of the fastest growing classes of new drugs. Compared to
traditional small molecule drugs, peptides typically have high activity and
specificity, low toxicity and a high degree of potential chemical diversity.
Several of the widely perceived disadvantages of peptide drugs, such as high
cost of manufacture, short half-life and poor bioavailability have been largely
addressed in recent years through the use of peptide libraries for target
screening, improvements in manufacturing, the use of non-natural amino acids to
increase stability and improvements in product formulation. By significantly
reducing the cost of high-quality custom peptides and peptide-based screening
tools for peptide users, Mimotopes aims to further stimulate activity in this
emerging and exciting field.
About Mimotopes - “The Peptide Company”
Established in 1989, Mimotopes Pty Ltd is one of the original peptide companies
and the founder of peptide library technology. With its main production facility
in Melbourne (Australia) and a new peptide R&D innovation centre near Shanghai
(China), Mimotopes' patented synthesis processes, high-quality production
facilities and experienced staff have made it one of the leading research-grade
peptide companies in the world.
Peptides are fragments of proteins that play an important role in modulating
many physiological processes and therefore have excellent potential as research
tools and therapeutic agents. Peptides have a number of advantages over
traditional drugs, including low toxicity and immunogenicity, excellent
specificity and high potency. They now represent one of the most active areas of
research and development in the drug discovery industry.
For online peptide shopping or more information from the peptide experts, visit
www.mimotopes.com
Further information:
Dr. Nick Ede
Chief Executive Officer
Mimotopes Pty Ltd
11 Duerdin Street
Clayton VIC 3168, Australia
Tel: + 61 3 9565 1111
Fax: + 61 3 9565 1199
Email:
mimotopes@mimotopes.com
| |
|
